JERRY JACOB GEORGE D.O. NPI 1972765733

NPI Details

Jerry Jacob George, D.O. is a hematology and oncology internal medicine in Port Jefferson Station, NY with 20 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. Jerry Jacob George, D.O. NPI is 1972765733. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: NEW YORK COLLEGE OF OSTEO MEDICINE OF NEW YORK INSTITUTE OF TECHNOLOGY
Graduation Year:2005

The provider's business location address is:

49 NESCONSET HWY
PORT JEFFERSON STATION, NY
ZIP 11776-628
Phone: (631) 751-3000
Fax: (631) 509-6559

The NPI 1972765733 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, ferric carboxymaltose, 1 mg (HCPCS:J1439)
• Injection, darbepoetin alfa, 1 microgram (non-esrd use) (HCPCS:J0881)
• Flow cytometry technique for dna or cell analysis, each additional marker (HCPCS:88185)
• Injection, denosumab, 1 mg (HCPCS:J0897)
• Injection, iron sucrose, 1 mg (HCPCS:J1756)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
• Gammaglobulin (immune system protein) measurement (HCPCS:82784)
• Folic acid level, serum (HCPCS:82746)
• Ferritin (blood protein) level (HCPCS:82728)
• Iron level (HCPCS:83540)
• Lactate dehydrogenase (enzyme) level (HCPCS:83615)
• Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month (HCPCS:99490)
• Vitamin d-3 level (HCPCS:82306)
• Uric acid level, blood (HCPCS:84550)
• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
• Red blood cell sedimentation rate, to detect inflammation, non-automated (HCPCS:85651)
• Magnesium level (HCPCS:83735)
• Protein measurement, serum (HCPCS:84165)
• Iron binding capacity (HCPCS:83550)
• Phosphate level (HCPCS:84100)
• Immunologic analysis technique on serum (immunofixation) (HCPCS:86334)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Red blood count, manual test (HCPCS:85044)
• Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
• Beta-2 microglobulin (protein) level (HCPCS:82232)
• Detection test by nucleic acid for organism, amplified probe technique (HCPCS:87798)
• Psa (prostate specific antigen) measurement, total (HCPCS:84153)
• Haptoglobin (serum protein) level (HCPCS:83010)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Flow cytometry technique for dna or cell analysis, first marker (HCPCS:88184)
• Blood test, clotting time (HCPCS:85610)
• Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Coagulation function measurement, d-dimer; quantitative (HCPCS:85379)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 (HCPCS:86300)
• Testosterone (hormone) level, total (HCPCS:84403)
• Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• Coagulation assessment blood test, plasma or whole blood (HCPCS:85730)
• Detection test by nucleic acid for multiple organisms, amplified probe(s) technique (HCPCS:87801)
• Injection, ondansetron hydrochloride, per 1 mg (HCPCS:J2405)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Urinalysis, manual test (HCPCS:81002)
• Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
• New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
• Hemoglobin a1c level (HCPCS:83036)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 19-9 (HCPCS:86301)
• Infusion into a vein for hydration, each additional hour (HCPCS:96361)
• Detection test for candida species (yeast), amplified probe technique (HCPCS:87481)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
• Leuprolide acetate (for depot suspension), 7.5 mg (HCPCS:J9217)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 125 (HCPCS:86304)
• Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
• Phosphatase (enzyme) measurement, acid, total (HCPCS:84060)
• Bilirubin level, total (HCPCS:82247)
• Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
• Infusion, normal saline solution, sterile (500 ml = 1 unit) (HCPCS:J7040)
• Thyroxine (thyroid chemical), total (HCPCS:84436)
• Acute hepatitis panel (HCPCS:80074)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
• Injection, fosnetupitant 235 mg and palonosetron 0.25 mg (HCPCS:J1454)
• Administration of influenza virus vaccine (HCPCS:G0008)
• Detection test by nucleic acid for strep (streptococcus, group a), amplified probe technique (HCPCS:87651)
• Detection test by nucleic acid for strep (streptococcus, group b), amplified probe technique (HCPCS:87653)
• Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen (HCPCS:87635)
• Detection test by nucleic acid for staphylococcus aureus (bacteria), amplified probe technique (HCPCS:87640)
• Ige (immune system protein) level (HCPCS:82785)
• Thyroxine (thyroid chemical), free (HCPCS:84439)
• Detection test by nucleic acid for vancomycin resistance strep (vre), amplified probe technique (HCPCS:87500)
• Measurement c-reactive protein for detection of infection or inflammation, high sensitivity (HCPCS:86141)
• Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
• Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
• Injection of drug or substance into vein (HCPCS:96374)
• Blood test, lipids (cholesterol and triglycerides) (HCPCS:80061)
• Rheumatoid factor level (HCPCS:86431)
• Parathormone (parathyroid hormone) level (HCPCS:83970)
• Infusion, normal saline solution, 250 cc (HCPCS:J7050)
• Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month (HCPCS:99439)
• Drawing of blood for a medical problem (HCPCS:99195)
• Influenza vaccine split virus, preservative free (HCPCS:90662)
• Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free (HCPCS:90674)
• Albumin (protein) level (HCPCS:82040)
• Gene analysis (calreticulin), common variants (HCPCS:81219)
• Gene analysis (janus kinase 2) variant (HCPCS:81270)
• Gene analysis (janus kinase 2) targeted sequence analysis (HCPCS:81279)
• Gene analysis (mpl proto-oncogene, thrombopoietin receptor) for detection of common variants (HCPCS:81338)
• Molecular pathology procedure; physician interpretation and report (HCPCS:G0452)
• Lactic acid level (HCPCS:83605)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Comprehensive assessment of and care planning for patients requiring chronic care management services (list separately in addition to primary monthly care management service) (HCPCS:G0506)

The enumeration date for this NPI number is 7/1/2008 and was last updated on 1/17/2020.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.